DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the NOCIL LIMITED (NOCIL) share price today?

NOCIL LIMITED (NOCIL) is trading at ₹162.7 on the NSE, down 2.11% on the day. Source: DocStoX.

What is the PE ratio of NOCIL LIMITED?

NOCIL LIMITED has a price-to-earnings (PE) ratio of 48.9 in the Chemicals sector.

What is the market capitalisation of NOCIL LIMITED?

NOCIL LIMITED has a market capitalisation of approximately ₹2,729 crore.

NOCIL LIMITED

NOCIL·NSE·Chemicals

₹162.70▼ -3.51 (-2.11%)

Chemicals · Specialty Chemicals

Revenue under pressure recently

Day₹161.27

₹166.20

52W₹125

₹20547%

Open

₹165.60

High

₹166.20

Low

₹161.27

Prev Close

₹166.21

Volume

2.74L

VWAP

₹162.78

Snapshot

Key fundamentals

Market Cap

₹2,729 Cr

P/E Ratio

48.86Expensive

P/B Ratio

1.69

EPS

₹3.33

Book Value

₹106.00

ROE

3.37%Weak

ROCE

5.00%Weak

Dividend Yield

0.84%

Debt / Equity

0.00Low

Face Value

₹10.00

52W High

₹204.50

52W Low

₹125.31

Sector

Chemicals

Industry

Specialty Chemicals

Avoid

None moatHigh uncertainty

Fair value estimate

₹92

▼ 43.2%downside

Trading at ₹163 — 43% above our estimate

BearFair valueBull

₹79₹92₹106

/100

Business quality — Watch the fundamentals

Growth 0Profitability 6Efficiency 0Valuation 51

Plain English

Our view

Revenue under pressure recently
Virtually debt-free balance sheet
Weak returns on equity (3%)

Strengths

Virtually debt-free balance sheet

Risks

Weak returns on equity (3%)
Revenue has been shrinking
Fundamental red flags (Piotroski 2/9)

How we got there

Fair value methods

Residual income

3% ROE fading to 13% over ~3 yrs, on ₹106 book

₹94

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹89

Analyst target

No analyst coverage

—

Blended fair value₹92

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet

Bear case

Weak returns on equity (3%)
Revenue has been shrinking
Fundamental red flags (Piotroski 2/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

48.9Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

3.4%Weak

Above 15% is considered healthy for Indian equities

ROCE

5.0%Weak

Above 18% means capital is working hard

Debt/Eq

0.00Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹2,729 Cr

P/B

1.69

EPS

₹3.33

Div Yield

0.84%

What changed

Recent changes

Domestic institutions+1.4% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 48.9×

Growth

Shrinking

-7% rev CAGR

Profitability

Modest

3.4% ROE

Financial health

Rock solid

D/E 0.00

Momentum

N/A

No technicals

Today

Trading activity

Delivery %49.9%

Turnover₹446.55L Cr

Trades4,761

VWAP₹162.78

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

-6.9%

+7.1%

10Y

+6.2%

Profit

-27.8%

-8.6%

10Y

-3.3%

EPS

-28.1%

-8.9%

10Y

-3.7%

Profile

Pros

Company has reduced debt.
Company is almost debt free.
Company has been maintaining a healthy dividend payout of 38.4%

Watch-outs

Cons

The company has delivered a poor sales growth of 7.10% over past five years.
Promoter holding is low: 33.8%
Company has a low return on equity of 4.98% over last 3 years.
Earnings include an other income of Rs.31.5 Cr.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Domestic institutions added 1.42 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

34%

Promoter

Promoters

33.8%0.00

Public

44.4%-0.83

FII / FPI

4.5%+0.08

DII

7.9%+1.42

Others

9.4%

Total shareholders

1,65,835+3,668 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter33.76%

FII4.55%

DII7.91%

Public44.36%

Others9.42%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

NOCIL LIMITED valuation & research

Deep-dive tools with DocStoX's fair-value estimate, ratios and peers.

Fair Value Intrinsic Value DCF Valuation Financial Ratios Peers

NOCIL LIMITED peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.

NOCIL LIMITED

Key fundamentals

Key statistics

Recent changes

News impact

Overview

Trading activity

Technical signals

Growth (CAGR)

Company information

Pros

Cons

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership breakdown

Ownership over time

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Frequently asked questions

NOCIL LIMITED valuation & research

NOCIL LIMITED peers in Chemicals

Key statistics

Recent changes

News impact

Trading activity

Technical signals

Growth (CAGR)

Company information

Pros

Cons

Ownership breakdown

Ownership over time

Frequently asked questions